Medical Industry Innovation Institute

Open Course 2020

Medical Industry Innovation Forum

[Theme] How COVID-19 brought Transformation to the Medical and Healthcare Industry


December, 2020 – March,2021 (8 sessions) 18:00 – 20:15

Webiner (The URL of the online lecture will be sent to you at a later date.)
Target Audience
200 people
  • Undergraduate and graduate students (from The University of Tokyo and other universities)
  • Medical Innovation Industry Institute members
  • Healthcare professionals from medical institutes, academic societies, industries including pharmaceutical and medical device companies
  • Other professionals with a strong interest in leading Innovation in the medical industry
Registration Fee
Please pay the fee via a single bank transfer payment. We will provide the account information at a later date
  • Regular: 45,000JPY,
  • Mi3 Member: 30,000JPY (It costs extra, annual membership fee 12,000 yen)
  • Student: Free, for 8 lectures. (Working students, please register in general)
Course Description

The forum will provide an opportunity to discuss and share advanced challenges for the promotion of the health and medical care industry by inviting speakers from industry, government, politics, academia, and medicine from Japan and overseas to speak on a wide range of topics. The theme of this year’s forum is “How COVID-19 brought Transformation to the Medical and Healthcare Industry. We will discuss the history of how a single infectious disease can transform the existing framework of the medical industry and society, as out of necessity new business models and new lifestyles are being established in response to the demands of the new era. We will examine and discuss a breadth of important consequences of the pandemic.

Contact Information

Forum office within Medical Innovation Industry Institute
Tel: +81-3-5842-3363

Dec.24th (Thu) “Exploring the nature of the novel coronavirus”
Nobuhiko Okabe
Director General, Kawasaki City Institute for Public Health, Kawasaki
Satoshi Kutsuna
Chief , Division of Preparedness and Emerging Infections, Disease Control and Prevention Center, International Health Care Center, National Center for Global health and Medicine
Jan.14th(Thu) “Policies for surviving the era with coronavirus, and THRIVING beyond”
Gaku Hashimoto

Member of the House of Representatives, former Vice Minister of Health, Labor and Welfare

Jan. 26th (Tue) “Kanagawa Prefecture Case Study”
Kenji Shuto
Vice Governor , Kanagawa Prefecture
Noriyuki Ashihara
Manager , Shonankamakura General Hospital
Kiyotaka Eguchi
Executive Officer ,Public Policy and CSR,LINE Corporation / Chief Information Officer and Chief Data Officer , Kanagawa Prefectural Government
Feb.9th (Tue) “FRONTIERS of drug development regulations”
Osamu Inagaki
Drug Evaluation Committie, Japan Pharmaceutical Manufactures Association(JPMA)(Astellas Pharma Inc.)
Haruko Yamamoto
Chief Medical Officer, Associate Executive Director, Pharmaceuticals and Medical Device Agency
Feb 25th(Thu) “FRONTIERS of vaccine science”
Satoshi Uchida
Associate Professor, Medical Chemistry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
Tetsuo Nakayama

Project Professor, Kitasato University, Ōmura Satoshi Memorial Institute

Yutaka Hishiyama
Director-General , National Institute of Science and Technology Policy (NISTEP), Ministry of Education, Culture, Sports, Science and Technology (MEXT)
*Date to be determined

*Lecturer to be arranged
(Overseas Incubator Top Management) 

Osamu Utsunomiya

President, Japan Dietary Habits Association (Former Director-General, Health Service Bureau, Ministry of Health, Labour and Welfare)

(assumed)Akira Miura

Counselor for Information Technology Management Minister’s Secretariat, Ministry of Health, Labour & Walfare

Mar.18th (Thu) “Inclusive healthcare accelerated by the pandemic”
Hiroyukui Kobayashi
Vice President , Digital Intelligence Department, Corporate Strategy Division
Makoto Suhara
Special Assistant to the Ambassador , Embassy of the Republic of Estonia in Japan / Representative in Japan Enterprise Estonia
Amina Sugimoto

Co-founder/CEO, fermata inc.

  • These are closed sessions, so photography, video and audio recording are prohibited.
  • We appreciate your cooperation and consideration.